Simpson Thacher in the News
Go Back
Sara Razi Quoted in Law360 on Upcoming Government Merger Trials
07.21.23
This is only gets display when printing
Sara Razi, Global Co-Chair of the Firm’s Antitrust and Trade Regulation Practice, was quoted in a Law360 article titled, “2023 Is Far From Done With Government Merger Cases.” The article discussed the FTC and DOJ’s upcoming merger trials aimed at continuing the current administration’s aggressive antitrust enforcement regime. This includes the FTC’s challenge to Amgen’s proposed $27.8 billion acquisition of Horizon Therapeutics, a case which Sara noted was unusual considering the two pharmaceutical companies do not compete. She further explained that “There are no merger guidelines today that cover this type of merger allegation.”
To read the full article, please click here (subscription required).